Profile data is unavailable for this security.
About the company
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
- Revenue in USD (TTM)12.14bn
- Net income in USD691.54m
- Incorporated1994
- Employees70.00k
- LocationDaVita Inc2000 16th StDENVER 80202-5158United StatesUSA
- Phone+1 (310) 536-2668
- Fax+1 (302) 636-5454
- Websitehttps://www.davita.com/
More ▼
Mergers & acquisitions
| Acquired company | DVA:NYQ since announced | Transaction value |
|---|---|---|
| Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,Brazil | 6.19% | 300.00m |
| Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,Ecuador | 6.19% | -- |
| Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,Colombia | 6.19% | -- |
| Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,Chile | 6.19% | -- |
Data delayed at least 15 minutes, as of Apr 26 2024 21:10 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ensign Group Inc | 3.73bn | 209.40m | 6.67bn | 35.30k | 32.08 | 4.45 | 23.65 | 1.79 | 3.66 | 3.66 | 65.07 | 26.36 | 0.9776 | -- | 8.35 | 105,647.50 | 5.50 | 6.45 | 6.66 | 7.88 | 21.68 | 22.32 | 5.63 | 6.48 | -- | 39.17 | 0.0908 | 6.56 | 23.27 | 16.28 | -6.80 | 28.62 | 4.40 | 5.02 |
| Acadia Healthcare Company Inc | 2.93bn | -21.67m | 6.78bn | 17.00k | -- | 2.41 | 58.12 | 2.32 | -0.2432 | -0.2432 | 32.07 | 30.48 | 0.5661 | -- | 8.56 | 172,278.70 | -0.3027 | 2.32 | -0.3528 | 2.64 | -- | -- | -0.5347 | 5.60 | 0.6669 | 6.17 | 0.3222 | -- | 12.20 | 8.99 | -107.93 | -- | 3.34 | -- |
| Encompass Health Corp | 4.80bn | 361.60m | 8.28bn | 22.36k | 23.18 | 5.03 | 11.06 | 1.73 | 3.57 | 3.45 | 47.38 | 16.43 | 0.818 | -- | 8.36 | 214,761.10 | 8.09 | 6.37 | 10.21 | 7.94 | 95.45 | 95.58 | 9.89 | 9.16 | -- | 5.29 | 0.5415 | 30.78 | 10.41 | 2.34 | 41.31 | 4.49 | 16.60 | -10.42 |
| Chemed Corp | 2.29bn | 283.41m | 8.68bn | 15.09k | 30.86 | 7.33 | 25.14 | 3.78 | 18.58 | 18.58 | 150.33 | 78.18 | 1.45 | 138.48 | 13.85 | 152,017.80 | 17.94 | 19.53 | 21.86 | 24.64 | 35.47 | 34.60 | 12.36 | 12.60 | 1.88 | -- | 0.00 | 8.15 | 6.06 | 4.90 | 9.17 | 5.80 | 1.46 | 6.10 |
| Tenet Healthcare Corp | 20.55bn | 611.00m | 9.67bn | 78.14k | 16.72 | 6.06 | 4.43 | 0.4707 | 5.83 | 5.83 | 196.00 | 16.09 | 0.7409 | 8.80 | 6.58 | 262,950.40 | 4.73 | 3.61 | 6.75 | 5.09 | 82.53 | 82.97 | 6.38 | 4.95 | 1.42 | 4.15 | 0.7315 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
| Solventum Corp | 8.20bn | 1.35bn | 10.68bn | 22.01k | 7.92 | 0.9154 | 5.60 | 1.30 | 7.80 | 7.80 | 47.53 | 67.55 | -- | -- | -- | 372,472.40 | -- | -- | -- | -- | 57.25 | -- | 16.42 | -- | 0.9618 | -- | 0.00 | -- | 0.8241 | -- | 0.2234 | -- | -- | -- |
| Universal Health Services, Inc. | 14.66bn | 816.29m | 11.01bn | 73.35k | 14.00 | 1.77 | 7.92 | 0.7508 | 11.79 | 11.79 | 211.29 | 93.13 | 1.06 | -- | 6.77 | 199,837.00 | 5.96 | 6.44 | 6.98 | 7.63 | -- | -- | 5.61 | 6.55 | 1.28 | 6.16 | 0.4352 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
| Davita Inc | 12.14bn | 691.54m | 11.64bn | 70.00k | 17.92 | 11.17 | 6.84 | 0.9591 | 7.41 | 7.41 | 130.29 | 11.89 | 0.7179 | 65.97 | 5.89 | 173,430.70 | 5.66 | 5.62 | 7.55 | 7.45 | 31.47 | 30.70 | 7.88 | 8.33 | 1.13 | 4.77 | 0.7536 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
| Quest Diagnostics Inc | 9.29bn | 842.00m | 15.04bn | 40.00k | 18.22 | 2.34 | 11.41 | 1.62 | 7.43 | 7.43 | 82.00 | 57.95 | 0.6944 | 33.57 | 7.21 | 232,175.00 | 6.51 | 9.28 | 7.61 | 10.81 | 32.95 | 36.64 | 9.37 | 12.97 | 0.8908 | 8.40 | 0.4184 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
| Laboratory Corporation of Amerc Holdings | 12.30bn | 399.20m | 16.69bn | 67.00k | 43.43 | 2.10 | 17.27 | 1.36 | 4.57 | 4.95 | 142.45 | 94.42 | 0.6698 | 18.59 | 4.68 | 183,588.10 | 2.18 | 6.27 | 2.68 | 7.37 | 27.74 | 32.33 | 3.25 | 9.51 | 0.7564 | 6.37 | 0.3934 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
Data as of Apr 26 2024. Currency figures normalised to DaVita Inc's reporting currency: US Dollar USD
62.21%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Berkshire Hathaway, Inc. (Investment Management)as of 14 Feb 2024 | 36.10m | 41.16% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 6.09m | 6.94% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 3.19m | 3.64% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 2.49m | 2.84% |
| LSV Asset Managementas of 31 Dec 2023 | 1.37m | 1.56% |
| Invesco Capital Management LLCas of 31 Dec 2023 | 1.29m | 1.47% |
| Geode Capital Management LLCas of 31 Dec 2023 | 1.23m | 1.40% |
| Dimensional Fund Advisors LPas of 31 Dec 2023 | 1.05m | 1.20% |
| Gates Capital Management, Inc.as of 31 Dec 2023 | 905.83k | 1.03% |
| 8 Knots Management LLCas of 31 Dec 2023 | 854.37k | 0.97% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
